Crossmark

High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors

Crossref DOI link: https://doi.org/10.1245/s10434-019-07878-8

Published Online: 2019-09-30

Published Print: 2020-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nakazawa, Nobuhiro

Yokobori, Takehiko

Kaira, Kyoichi

Turtoi, Andrei

Baatar, Seded

Gombodorj, Navchaa

Handa, Tadashi

Tsukagoshi, Mariko

Ubukata, Yasunari

Kimura, Akiharu

Kogure, Norimichi

Ogata, Kyoichi

Maeno, Toshitaka

Sohda, Makoto

Yajima, Toshiki

Shimizu, Kimihiro

Mogi, Akira

Kuwano, Hiroyuki

Saeki, Hiroshi

Shirabe, Ken
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (17K19893)

Japan Society for the Promotion of Science (18K07665)

Japan Society for the Promotion of Science (18H02877)
License Information

Text and Data Mining valid from 2019-09-30

Version of Record valid from 2019-09-30
More Information

Article History

Received: 10 February 2019

First Online: 30 September 2019

Disclosures

: Kyoichi Kaira has received research grants and a speaker honorarium from ONO PHARMACEUTICAL CO., LTD. and Bristol-Myers Squibb K.K.

Document is current

Any future updates will be listed below